You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 115 No. 9, September 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  LABORATORY SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Elevated {gamma}-Aminobutyric Acid, Glutamate, and Vascular Endothelial Growth Factor Levels in the Vitreous of Patients With Proliferative Diabetic Retinopathy

Jayakrishna Ambati, MD; Kakarla V. Chalam, MD, FRCSC; Dinesh K Chawla, MD; Carl T. D'Angio, MD; Ernest G. Guillet, MD, PhD; Steven J. Rose, MD; Robert E. Vanderlinde, MD; Balamurali K. Ambati, MD

Arch Ophthalmol. 1997;115(9):1161-1166.


Abstract

Objective
To examine the relative levels of {gamma}-aminobutyric acid (GABA), glutamate, and vascular endothelial growth factor (VEGF) in the vitreous of nondiabetic and diabetic patients.

Methods
Undiluted vitreous samples were obtained from 22 patients with proliferative diabetic retinopathy (PDR) and 28 patients without diabetes who underwent pars plana vitrectomy. Simultaneous venous blood samples also were obtained. Amino acid concentrations were determined using sensitive high-performance liquid chromatography, and VEGF levels by quantitative enzyme-linked immunosorbent assay. Hemoglobin concentrations in the blood and vitreous were determined using spectrophotometry.

Results
The level of GABA in the vitreous of patients with PDR, 29.4±7.8 µmol/L, was significantly higher than in controls (18.4±5.5 µmol/L) (P=.004). The vitreous concentration of glutamate was higher in patients with PDR (24.7±14.0 µmol/L) compared with controls (9.1±5.1 µmol/L) (P<.001). Vitreous VEGF level was significantly higher in patients with PDR (1759±1721 pg/mL) compared with controls (27±65 pg/mL) (P<.001). There were moderately strong correlations between GABA and VEGF levels (r=0.68) and glutamate and VEGF levels (r=0.43). Elevated GABA, glutamate, and VEGF levels also correlated strongly with the presence of PDR. Correcting for possible introduction of these molecules by vitreous hemorrhage did not significantly alter these findings.

Conclusions
Levels of glutamate potentially toxic to retinal ganglion cells are found in the vitreous of patients with PDR. Elevated vitreous GABA may reflect amacrine cell dysfunction and underlie electroretinographic oscillatory potential abnormalities seen in diabetic retinopathy. The correlations of glutamate and GABA levels with an elevated VEGF level provide biochemical support for ischemia-induced neovascularization in patients with PDR. These findings present opportunities for novel therapeutic modalities in the treatment of PDR.



Author Affiliations

From the Departments of Ophthalmology (Drs J. Ambati, Chawla, Guillet, Rose, and Vanderlinde) and Pediatrics (Dr D'Angio), University of Rochester, Rochester, NY; the Department of Ophthalmology, University of South Carolina, Columbia (Dr Chalam); and the Department of Medicine, Beth Israel Medical Center, New York, NY (Dr B. Ambati).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Retinal ganglion cells in diabetes
Kern and Barber
J. Physiol. 2008;586:4401-4408.
ABSTRACT | FULL TEXT  

Early Inner Retinal Dysfunction in Streptozotocin-Induced Diabetic Rats
Kohzaki et al.
IOVS 2008;49:3595-3604.
ABSTRACT | FULL TEXT  

Effect of Memantine on Neuroretinal Function and Retinal Vascular Changes of Streptozotocin-Induced Diabetic Rats
Kusari et al.
IOVS 2007;48:5152-5159.
ABSTRACT | FULL TEXT  

Neuroprotective Effects of Angiotensin II Type 1 Receptor (AT1R) Blocker, Telmisartan, via Modulating AT1R and AT2R Signaling in Retinal Inflammation
Kurihara et al.
IOVS 2006;47:5545-5552.
ABSTRACT | FULL TEXT  

Diabetes Alters Sphingolipid Metabolism in the Retina: A Potential Mechanism of Cell Death in Diabetic Retinopathy
Fox et al.
Diabetes 2006;55:3573-3580.
ABSTRACT | FULL TEXT  

Flt-1 Intraceptor Induces the Unfolded Protein Response, Apoptotic Factors, and Regression of Murine Injury-Induced Corneal Neovascularization
Singh et al.
IOVS 2006;47:4787-4793.
ABSTRACT | FULL TEXT  

Elevated glucose changes the expression of ionotropic glutamate receptor subunits and impairs calcium homeostasis in retinal neural cells.
Santiago et al.
IOVS 2006;47:4130-4137.
ABSTRACT | FULL TEXT  

Plasminogen activators promote excitotoxicity-induced retinal damage
Mali et al.
FASEB J. 2005;19:1280-1289.
ABSTRACT | FULL TEXT  

Flt-1 Intraceptors Inhibit Hypoxia-Induced VEGF Expression In Vitro and Corneal Neovascularization In Vivo
Singh et al.
IOVS 2005;46:1647-1652.
ABSTRACT | FULL TEXT  

Death of Retinal Neurons in Streptozotocin-Induced Diabetic Mice
Martin et al.
IOVS 2004;45:3330-3336.
ABSTRACT | FULL TEXT  

Proteome Analysis of Human Vitreous Proteins
Yamane et al.
Mol. Cell. Proteomics 2003;2:1177-1187.
ABSTRACT | FULL TEXT  

Retinal Neuronal Death Induced by Intraocular Administration of a Nitric Oxide Donor and Its Rescue by Neurotrophic Factors in Rats
Takahata et al.
IOVS 2003;44:1760-1766.
ABSTRACT | FULL TEXT  

Vitreous Amino Acid Concentrations in Patients With Glaucoma Undergoing Vitrectomy
Honkanen et al.
Arch Ophthalmol 2003;121:183-188.
ABSTRACT | FULL TEXT  

Diabetes-Induced Dysfunction of the Glutamate Transporter in Retinal Muller Cells
Li and Puro
IOVS 2002;43:3109-3116.
ABSTRACT | FULL TEXT  

Vitreous Levels of Vascular Cell Adhesion Molecule and Vascular Endothelial Growth Factor in Patients With Proliferative Diabetic Retinopathy: A case-control study
Hernández et al.
Diabetes Care 2001;24:516-521.
ABSTRACT | FULL TEXT  

Concurrent Downregulation of a Glutamate Transporter and Receptor in Glaucoma
Naskar et al.
IOVS 2000;41:1940-1944.
ABSTRACT | FULL TEXT  

Elevated Glutamate Levels in the Vitreous Body of an In Vivo Model of Optic Nerve Ischemia
Kim et al.
Arch Ophthalmol 2000;118:533-536.
ABSTRACT | FULL TEXT  

Comparison of the levels of hepatocyte growth factor and vascular endothelial growth factor in aqueous fluid and serum with grades of retinopathy in patients with diabetes mellitus
Shinoda et al.
Br J Ophthalmol 1999;83:834-837.
ABSTRACT | FULL TEXT  

Interferon-Induced Protein 10 and Interleukin 8: C-X-C Chemokines Present in Proliferative Diabetic Retinopathy
Elner et al.
Arch Ophthalmol 1998;116:1597-1601.
ABSTRACT | FULL TEXT  

Elevation of Intraocular Glutamate Levels in Rats With Partial Lesion of the Optic Nerve
Yoles and Schwartz
Arch Ophthalmol 1998;116:906-910.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.